Home
/
R & D
/
Unlearn
Unlearn
Unlearn

Unlearn

Optimize the accuracy of clinical trials.

Categories

Health
Model IA
Data analysis
Legislation
R & D
Visit the site
-
%
Code:
with our link

Description

This artificial intelligence makes it possible to generate digital twins for clinical trial participants, offering a detailed prediction of their future health status. These predictive models are trained with meaningful patient data from previous studies. The use of digital twins in TwinRCTs makes it possible to improve the power of trials without increasing the number of participants, in line with FDA and EMA guidelines. It also reduces the time required to reach full enrollment in late-stage studies and increases the likelihood that participants will receive the experimental treatment by reducing the size of control groups. By predicting the outcome of each participant in the control group, regardless of their actual assignment in the trial, Unlearn strengthens the ability of researchers to take confident decisions from the early stages of the key tests. Its effectiveness and adaptability make this tool a valuable resource for all professionals involved in clinical research on diseases such as Alzheimer's, amyotrophic lateral sclerosis and many others.

Plan prices

Basique

Advanced

Pro

Waiting list
€/month
Reserve
A demo
Gratuit
When using
€/month
Gratuit
Icon cross
Reserve
A demo
When using
Gratuit
Icon cross
€/month
Reserve
A demo

Features

API
Computer icon
Web app

Who is using this AI?

No items found.

Features

Accelerating enrollment processes for late-stage studies

Digital patient models help speed up the process Registration in late-phase studies by requiring fewer patients to achieve the same effectiveness. This optimizes resources and reduces time frames, offering a significant advantage for healthcare professionals involved in clinical research.

Improving the accuracy of decisions at the start of the study

The use of digital twins increases the power of early clinical trials without increasing the number of participants. This improves significantly Precision observations of the effects of treatments, allowing more informed and early decisions in the development of new therapies.

Increased attraction of study participants

By reducing the size of the control groups, TwinRCTs offer a greater probability for participants to receive the experimental treatment. This approach is not only increasing attractiveness of the study for potential participants but also ensures an ethical approach by limiting exposure to non-beneficial treatments.

Social networks

Twitter logo X
LinkedIn logoInstagram logoYouTube logoDiscord logoGithub logo

Comparison with other artificial intelligences

AI tool
Description
Category
Pricing
Features
Use

Unlearn

Optimize the accuracy of clinical trials.
R & D
free trial days
then
€/month
software API logo
five star iconFour star iconicon 3 starsTwo star iconIcon a star

Validator

Validate your idea, then develop your start-up.
R & D
Gratuit
then
0.0
€/month
software API logo
five star iconFour star iconicon three starsTwo star iconIcon a star

Stratup.ai

Generate business ideas and tools.
R & D
1er plan gratuit
then
15.0
€/month
Open source software logo
five star iconFour star iconicon three starsTwo star iconIcon a star

Discover our bespoke blog post

Get The Best of AI

The best AIs, business ideas and promotions
lacreme.ai robot mascot

Do you have an AI software to promote on Lacreme?

Write my form